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Abstract.  We have used Chinese hamster ovary 
(CHO) cells and a murine lymphoma cell line to study 
the recycling of the 215-kD and the 46-kD mannose 
6-phosphate receptors to various regions of the Golgi 
to determine the site where the receptors first encoun- 
ter newly synthesized lysosomal enzymes. For assess- 
ing return to the trans-most  Golgi compartments con- 
raining  sialyltransferase (trans-cisternae and trans-Golgi 
network), the oligosaccharides of receptor molecules 
on the cell surface were labeled with [3H]galactose at 
4~  Upon warming to 37~  the [3H]galactose 
residues on both receptors were substituted with sialic 
acid with a  t,/2 --3 hrs.  Other glycoproteins acquired 
sialic acid at least 8-10 times slower. Return of the 
receptors to the trans-Golgi  cisternae containing galac- 
tosyltransferase could not be detected.  Return to the 
cis/middle  Golgi cisternae containing  tz-mannosidase I 
was measured by adding deoxymannojirimycin, a man- 
nosidase I inhibitor,  during the initial  posttranslational 
passage of [3H]mannose-labeled glycoproteins through 
the Golgi, thereby preserving oligosaccharides which 
would be substrates for ~t-mannosidase I. After 
removal of the inhibitor,  return to the early Golgi with 
subsequent passage through the Golgi complex was 
measured by determining  the conversion of the oligo- 
saccharides from high mannose to complex-type units. 
This conversion was very slow for the receptors and 
other glycoproteins (t~  ~20 h).  Exposure of the recep- 
tors and other glycoproteins to the dMM-sensitive 
~t-mannosidase without movement through the Golgi 
apparatus  was determined by measuring  the loss of 
mannose residues from these proteins.  This loss was 
also slow. 
These results indicate that both Man-6-P receptors 
routinely return to the Golgi compartment which con- 
tains  sialyltransferase and recycle through  other 
regions of the Golgi region less frequently. We infer 
that the trans-Golgi network is the major site for 
lysosomal enzyme sorting in CHO and murine lym- 
phoma cells. 
I 
T is now well established that  newly synthesized  lyso- 
somal enzymes are sorted from secretory proteins  and 
routed to lysosomes by means of the mannose 6-phos- 
phate (Man-6-P) ~ recognition system (39, 54, 62). The lyso- 
somal  enzymes are synthesized  in the rough  endoplasmic 
reticulum and translocated to the Golgi apparatus where they 
acquire Man-6-P residues which act as recognition  markers 
for binding  to the Man-6-P receptors.  The receptor-ligand 
complex then exits the Golgi region and moves to an acidified 
compartment where the low pH causes the complex to dis- 
sociate. The receptor can recycle back to the Golgi region or 
to the cell surface while the lysosomal enzymes are packaged 
into  lysosomes.  Since  mature  lysosomes lack  detectable 
Man-6-P receptor (24, 51, 64), it is assumed that an acidified 
pre-lysosomal compartment exists. A small percent of newly 
synthesized  lysosomal enzymes are secreted by most cells 
and a portion of these molecules may bind to the Man-6-P 
receptors present on the cell surface.  These receptor-ligand 
complexes are concentrated  in coated pits where they are in- 
L Abbreviations used in thispaper: Man-6-P, mannose 6-phosphate; TGN, 
trans-Golgi  network. 
ternalized  into endosomes. Endosome acidification  dissoci- 
ates the complexes,  freeing the receptor to recycle while the 
lysosomal enzymes continue to the lysosome. 
Two distinct  Man-6-P receptors have been identified and 
their primary structures  determined  through cDNA cloning 
(17, 35, 42, 50, 57). One is a 215-kD trans-membrane glyco- 
protein which binds lysosomal enzymes in a cation-indepen- 
dent manner,  while the other is a 46-kD trans-membrane 
glycoprotein  which  requires  divalent  cations  for optimal 
lysosomal enzyme binding.  The receptors have similar, but 
not identical,  binding  specificities  for various  phosphory- 
lated oligosaccharides  (36). Both receptors bind ligands best 
at slightly acidic pHs and release the ligands at pH 5.5 or be- 
low (23, 34, 36, 52), a property characteristic  of receptors 
which deliver ligands to acidified  compartments. 
While these aspects of the pathway are generally accepted, 
conflicting  results  have been presented as to where in the 
Golgi region the newly synthesized lysosomal enzymes first 
encounter  the  Man-6-P  receptors.  Brown  and  Farquhar, 
based on their immunolocalization  of the 215-kD Man-6-P 
receptor in pancreatic,  hepatic,  and epididymis epithelial 
￿9  The Rockefeller University Press, 0021-9525188/03/617/12 $2.00 
The Journal of Cell Biology, Volume 106, March 1988 617-628  617 cells, concluded that this receptor is concentrated in the cis- 
Golgi complex (12, 14). On this basis they proposed that 
lysosomal enzymes bind to the receptor in the cis-Golgi com- 
plex, and exit at this level. However, other groups studying 
different cell types with immunolocalization  techniques found 
the receptor to be concentrated mainly in the trans-Golgi net- 
work (TGN) (also termed trans-Golgi reticulum, tmns-tubular 
network, and GERL) with only very low levels  being de- 
tected in the Golgi stack (25-28, 33, 64). These data have led 
to the alternative hypothesis that the lysosomal enzymes pass 
through the entire Golgi apparatus before being segregated 
to lysosomes. Additional evidence in support of this second 
pathway comes from the finding that several  lysosomal en- 
zymes have been  shown to  contain terminally processed 
complex-type N-linked oligosaccharides in addition to their 
phosphorylated high mannose-type oligosaccharides (5, 22, 
29, 41, 46, 61). Since the glycosyltransferases responsible for 
terminal processing are located in the trans-Golgi cisternae 
and the TGN (6, 47, 48),  this finding indicates that at least 
a portion of the lysosomal enzymes pass through the entire 
Golgi stack enroute to the lysosome. It is still not clear, how- 
ever, exactly where lysosomal enzymes first come in contact 
with the Man-6-P receptors. 
In an attempt to resolve this controversy,  we set out to de- 
velop methods for analyzing the kinetics of receptor recy- 
cling to the different regions of the Golgi complex. The ap- 
proach takes advantage of the fact that the various enzymes 
involved in oligosaccharide processing are distributed among 
specific regions of the Golgi stack and the TGN (2-4,  6, 
19-21, 30, 44, 47-49). Consequently, these enzymes have the 
potential  to  mark receptors  which move through specific 
Golgi compartments, provided that the oligosaccharides on 
the mature receptors are suitable substrates for the Golgi en- 
zymes. Two experimental approaches have been used to ac- 
complish this.  First, the oligosaccharide units of receptor 
molecules present on the cell surface were modified so that 
they would become substrates for sialyltransferase, a marker 
of the trans-Golgi cisternae and the TGN (6, 48, 49). If these 
receptors then returned to the compartment containing sial- 
yltransferase, the oligosaccharide should gain a  sialic acid 
residue. The other method uses deoxymannojirimycin, a re- 
versible inhibitor of the early Golgi enzyme, ct-mannosidase 
I (8), to prevent the processing of oligosaccharides on newly 
synthesized glycoproteins during their initial pass through 
the Golgi apparatus. Subsequent removal of the inhibitor al- 
lows  Golgi ct-mannosidase I  to act upon those molecules 
which return to the early Golgi complex. If the molecules 
continue through the Golgi apparatus, they would then be- 
come substrates for the later stage processing enzymes. Our 
results indicate that in the cell types studied the two Man-6-P 
receptors  routinely return  to the  TGN but  rarely recycle 
through the entire Golgi apparatus. 
Materials and Methods 
Materials 
All reagents were of analytical grade.  [2-3H]Mannose (15 Ci/mmol) and 
[6-3H]galactose (20 Ci/mmol) were from American Radiolabeled Chemi- 
cals (St. Louis, MO). UDP-[6-3H]galactose (17 Ci/mmol) was from Amer- 
sham Corp. (Arlington Heights, IL). Sephadex G-25-80, bovine milk UDP- 
galactose/D-glucose ]31--4 galactosyltransferase, UDP-galactose, aprotinin, 
antipain, leupeptin, chymostatin, pepstatin, r  a-methyl- 
mannoside, glucose 6-phosphate,  and  mannose 6-phosphate were  from 
Sigma Chemical Co. (St.  Louis, MO).  Vibrio cholera  neuraminidase and 
pronase  were  from  Calbiochem-Behring  Corp.  (San  Diego,  CA).  De- 
oxymannojirimycin was from Miles Laboratories  (Naperville,  IL).  Con 
A-Sepharose was from Pharmacia Fine Chemicals (Piscataway,  NJ). RCA-I 
agarose was from E-Y Labs (San Mateo, CA). Phosphomannan-Sepharose 
was prepared as previously described (35). Jack bean [3-galactosidase was 
provided by Walter Gregory of Washington University (St.  Louis, MO). 
New Castle disease virus containing an ct 2-3 specific neuraminidase was 
a  kind gift of Dr.  Jacques Baenziger, Washington University (St.  Louis, 
MO). 
Cel/s 
BW 5147 mouse lymphoma cells and the galactose-deficient cell line BW 
5147 PHAR1.8 derived from it (60) were grown as a suspension culture in 
ct-MEM containing 10% FCS and antibiotics (complete medium). Two Chi- 
nese hamster ovary (CHO) galactose-deficient lines were used. The WGA- 
resistant CHO clone 13 line (11) was grown in suspension culture while the 
CHO ldl-D line (37) obtained from M. Kreiger (MIT, Cambridge, MA) was 
grown as a monolayer. Cells were harvested as they neared maximal density. 
While the three galactose-deficient cell lines are similar in phenotype, 
they have two different underlying defects. CHO clone 13 cells synthesize 
normal amounts of UDP-Gal, but are unable to transport this nucleotide 
sugar from the cytosol into the lumen of the Golgi cisternae (11, 18). In the 
absence of its sugar donor, galactosyltransferase cannot function. The BW 
5147 PHAal.8 cells appear to have a similar defect (60). In contrast, CHO 
ldl-D cells are unable to form UDP-Gal from UDP-GIc due to a deficiency 
of the UDP-Glc/UDP-Gal epimerase enzyme (37).  The effects of this muta- 
tion can be circumvented by adding galactose to the culture medium since 
a pathway exists for forming UDP-Gal directly from galactose. 
Surface Labeling of CHO Clone 13 and 
BW 5147 PHAR1.8 
Cells were cooled on ice, collected by centrifugation and resuspended to a 
density of 1 ￿  l0  g cells/ml in ice-cold glucose and bicarbonate-free MEM 
containing 20 mM Hepes, pH 7.4 (GBFM). To begin the surface labeling, 
MnCI2, galactosyltransferase and UDP-[3H]Gal were added to final con- 
centrations of 10 mM, 0.5-1.0 U/ml and 0.05-0.1 mCi/ml, respectively. Af- 
ter a 30-min incubation at 4~  with end-over-end mixing, unlabeled UDP- 
galactose was added to a final concentration of 2.5 mM and the incubation 
continued for  10 min.  The cells  were  then collected by  centrifugation, 
washed once with complete medium, and when desired, warmed to 37~ 
by diluting 200-fold into pre-warmed complete medium containing 20 mM 
Hepes, pH 7.4. After the indicated times at 370C,  the cells were collected 
by centrifugation at 4~  washed once with cold PBS, and the cell pellets 
frozen. 
Surface Labeling of CHO ldl-D 
Cells were grown to confluence in 150-mm dishes. Where indicated, cyclo- 
heximide was added to 50 p.g/ml  1 h before cooling the cells to 4~  The 
cultures were washed twice with cold GBFM and then 9.75 ml of GBFM 
was added to each dish followed by the addition of MnCI2, galactosyltrans- 
ferase and UDP-[3H]Gal to final concentrations of 10 mM, 0.025  U/ml and 
5 ~tCi/ml. After a  l-h incubation at 4~  the medium was removed and the 
cultures washed once with GBFM. Each dish then received 10 ml GBFM 
containing  10 mM MnCI2,  0.012 U  galactosyltransferase, and 0.25  mM 
UDP-Gal. After a 10-min incubation at 4~  the cultures were washed twice 
with cold complete medium. The cultures were then warmed to either 20~ 
or  37~  by  adding 25  ml of pre-warmed complete medium containing 
20 mM Hepes,  pH 7.4.  After the indicated time, the cells were washed 
twice  with  cold  PBS,  scraped,  collected by centrifugation, and the cell 
pellets frozen. This surface labeling procedure is similar to that used by 
other groups to label a variety of cell types (58, 59). 
Neuraminidase Treatment of CHO ldl-D Cells 
Cells were plated into 60-mm dishes and grown in complete medium. 3 h 
before labeling the medium was replaced with 2 ml of r  lacking se- 
rum (a source of galactose) to decrease the intracellular pool of galactose. 
The labeling was initiated by replacing the serum-free medium with 2 ml 
of MEM containing 1% dialyzed calf serum, 20 mM Hepes pH 7.4 and 0.1 
mCi/ml [3H]galactose.  After a 20-h incubation, the medium was removed 
and the cells washed three times. The chase was then begun by the addition 
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GalNAc, and 20 mM Hepes pH 7.4 (chase medium). After a 2-h chase, the 
medium was removed and replaced with 2 ml of chase medium containing 
0.1 U/ml V. cholerae neuraminidase. After 3-4 h at 37~  the cells were 
washed four times to remove the neuraminidase, and then incubated in chase 
medium lacking neuraminidase. At the indicated times throughout the ex- 
periments, the cells were cooled to 4~  washed three times with cold PBS, 
scraped, pelleted by centrifugation, and cell pellets frozen. 
Analysis of  Endogenous Galactose  Addition to 
the Man-6-P Receptors in BW 5147 PHAR1.8 
Cells were collected by centrifugation and suspended to a density of 1 x 
107 cells/nil in GBFM containing 0.1 mCi/ml [3H]mannose.  After a 40-min 
incubation, the cells were centrifuged, and resuspended at a density of l 
x  106 cells/ml in complete medium to initiate the chase. At the indicated 
times, cells were collected by centrifugation at 4~  washed once with cold 
PBS and the cell pellets frozen. 
The Man-6-P receptors were purified (see below) and the fraction con- 
taining galactose assessed by RCA-I agarose chromatography. The receptors 
in column buffer (50 mM Imidazole pH 6.5,  150 mM NaCl, 0.05%  Triton, 
10 l~g/ml BSA and either 5 mM EDTA or 10 mM MnCl2) were applied to 
a 1.13 ml RCA-I agarose column equilibrated in the same buffer. The column 
was washed and eluted with column buffer containing 0.2 M galactose. Frac- 
tions of the run through, wash and eluate were monitored for radioactivity. 
To release terminal sialic acid,  the 46-kD Man-6-P receptor (in column 
buffer) and the 215-kD  Man-6-P receptor (in column buffer containing 
lO mM CaCl2) were incubated with 0.1 U/ml V. cholerae neuraminidase for 
6 h at 37~  before chromatography on RCA-I agarose. 
Deoxymannofirimycin Inhibition of  Oligosaccharide 
Processing in BW 5147 Cells 
Cells were collected by centrifugation and resuspended to a density of 1 x 
t07 cells/ml in GBFM containing 0.25 mM deoxymannojirimycin. After a 
60-min incubation at 37~  [3H]mannose was added to a final concentra- 
tion of 0.1 mCi/ml, and the incubation continued for 40 rain. The cell sus- 
pension was then diluted 3-fold with complete medium containing 20 mM 
Hepes pH 7.4,  10 mM mannose and 0.25  mM dMM to initiate the chase. 
After 6 h at 37~  the cells were sedimented, washed three times with com- 
plete medium lacking dMM,  and resuspended to a  density of l  x  l06 
cells/ml in complete medium containing Hepes and mannose but lacking 
dMM. After the indicated times at 37~  the cells were collected by cen- 
trifugation in the cold, washed once with cold PBS and the celt pellet frozen. 
Purification of the Mannose 6-Phosphate Receptors 
The two Man-6-P receptors were purified by a modification of our previ- 
ously described method (35). The frozen cells were resuspended in 6 ml 
of 50  mM  Hepes pH 7.4,  5  mM  NaPO4,  5  mM EDTA,  0.34  TIU/ml 
aprotinin, 1:200 dilution of a cocktail of protease inhibitors (2.5 mg/ml of 
antipain,  pepstatin,  chymostatin,  leupeptin,  and  10  TIU/ml  aprotinin), 
2 mM Man-6-P and sonicated by 3 10-s bursts (power level 2) from a Bran- 
son Sonifer model 350 (Danbury, cr). Saponin was added to a final concen- 
tration of 0.5% and the mixture held on ice for 30 min. Membranes were 
sedimented at 80000 g for 30 min, the supernatant fluid removed, and the 
pellet resuspended in 6 ml of 25 mM Hepes pH 7.4,  0.1 M NaC1,  5 mM 
NaPO4,  0.17 TIU/ml Trasylol,  0.5%  saponin. The membranes were in- 
cubated on ice for 15 rain, resedimented and the wash repeated. Membrane 
proteins were solubilized by resuspending the membrane pellet in 3 ml of 
50 mM Imidazole pH 6.5, 150 mM NaCI, 5 mM EDTA~ 1.0% Triton 3:-100, 
0.t% SDS, 0.02% NAN3, 1:200 dilution of protease inhibitors and incubat- 
ing overnight on ice, The solution was sedimented at 80,OO0 g for 30 min 
to remove insoluble material and the supernatant applied to a  phospho- 
mannan-Sepharose column (0.6  rnl bed volume). The column was then 
washed with 15 ml of solubilization buffer.  Under these conditions, the 215- 
kD Man-6-P receptor binds to the column while the 46-kD Man-6-P recep- 
tor runs through. The first 15 ml of the column run through, containing the 
46-kD Man-6-P receptor, was brought to 20 mM MnCI2 and applied to a 
second phosphomannan column-Sepharose equilibrated in  solubilization 
buffer containing 20 mM MnCI2. Under these conditions, the 46-kD Man- 
6-P receptor binds to this affinity matrix. Each column was then washed 
with  15 ml of solubilization buffer containing 0.1 mg/ml BSA and either 
EDTA or MnCI2, followed by 100 ml of 50 mM Imidazole pH 6.5,  150 mM 
NaCI, 0.05% Triton X-t00, 10 ~tg/ml BSA and either 5 mM EDTA or 10 mM 
MnC12 (column buffer). After a final wash with column buffer containing 
2 mM glucose 6-phosphate, the receptors were eluted from the affinity ma- 
trix using column buffer containing 5 mM Man-6-P. All steps were done 
at 4~  Analysis of each receptor fraction by SDS-PAGE revealed a single 
band of appropriate size (data not shown). 
TCA Precipitation and Pronase Digestion 
The purified receptors or the run through fraction obtained from the second 
phosphomannan column (total membrane glycoproteins) were precipitated 
with cold TCA (20%  final  concentration) and centrifuged at  11,0OO g  for 
5 rain. The pellets were washed with acetone and then with EhO/EtOH 
(3:1).  The dried pellets were suspended in 0.2 ml of 100 mM Tris pH 8.0, 
20 mM CaCI2,  113 mg/ml pronase and incubated overnight at 56~  to de- 
grade the glycoproteins to glycopeptides. The samples were then boiled for 
10 min, clarified by centrifugation and the supernatant fluid recovered. 
Structural Analysis of  Glycopeptides 
Details of Con A-Sepharose chromatography, endo H digestion and HPLC 
sizing of the high mannose oligosaccharides are described elsewhere (30, 
40,  43).  To assess the extent of sialylation, [3H]galactose-labeled glyco- 
peptides were desalted by Sephadex G-25 chromatography, evaporated to 
dryness and resuspended in 0.15 ml of 40 mM NaOAc pH 4.6 containing 
0.05 U 13-galactosidase. The reaction mixtures were incubated at 37~  for 
72 h under a toluene atmosphere with additional I~-galactosidase  (0.025 U) 
added at 24 and 48 h.  The [3H]galactose  released by this treatment was 
then quantified by Sephadex G-25 chromatography. To release sialic acid, 
samples were treated with a  l:100  dilution of New Castle disease virus 
(which contains an a  2-3 specific neuraminidase) in 50 mM NaCacodylate 
pH 6.0 for 24 h at 37~  under a toluene atmosphere or with 2N HOAc for 
I  h  at  100~ 
Results 
Receptors Return to the Golgi Compartment 
Containing Sialyltransferase 
Sialyltransferase is a  late acting Golgi enzyme which has 
been immunolocalized to the trans-cisternae and the TGN 
in rat liver hepatocytes (48).  Therefore, this enzyme was 
selected as a marker of these compartments. To determine 
whether Man-6-P receptors present on the cell surface return 
to the Golgi compartments containing sialyltransferase, two 
approaches were used. The first is schematized in Fig. 1. In- 
tact cells were cooled to 4~  to arrest endocytosis and incu- 
bated with UDP-[3H]Gal and galactosyltransferase to trans- 
fer [3H]galactose residues to the Man-6-P receptor molecules 
present on the cell surface. To increase the extent of  the label- 
ing, three mutant cell lines, BW 5147 PHAR1.8 cells, CHO 
clone 13 cells and CHO ldl-D cells were used. Each of these 
cell lines is impaired in the incorporation of galactose into 
N-linked oligosaccharides and therefore the glycoproteins 
are enriched in terminal GlcNAc residues and serve as much 
better substrates for the galactosyltransferase. Preliminary 
experiments  demonstrated  that  both  Man-6-P  receptors 
could be labeled at the cell surface of  each cell type and were 
internalized upon warming to 37~  with a half time of ~2 
min, as judged by resistance to external proteases (data not 
shown). To assess whether they acquired sialic acid after in- 
ternalization,  the  receptors  were  purified,  digested  with 
pronase  to  generate  glycopeptides and  the  glycopeptides 
treated with [~-galactosidase.  ~Galactosidase is an exogly- 
cosidase that only releases terminal galactose residues and 
therefore any addition of sialic acid will block cleavage by 
this enzyme. After digestion with 13-galactosidase,  the re- 
leased galactose was separated from the resistant sialylated 
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Figure 1. Experimental protocol used for cell surface labeling and 
subsequent analysis of sialic acid addition. 
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Figure 2. The Man-6-P receptors acquire sialic acid following sur- 
face labeling.  Surface glycoproteins of BW 5147 PHAR1.8 cells 
were labeled with [3H]galactose  using galactosyltransferase as de- 
scribed in Materials and Methods. The cells were then kept at 4~ 
(A, C, and E) or warmed to 37~  for 3.3 h (B, D, and F). The 215- 
kD Man-6-P receptor (A and B), 46-kD Man-6-P receptor (C and 
D) and total glycoproteins (E and F) were prepared, digested to 
glyeopeptides with pronase, treated with 13-galactosidase and ana- 
lyzed by gel filtration chromatography. The gel filtration profiles are 
shown and the relative positions of released [3H]galactose  (e) and 
glycopeptides  containing  sialylated  [3H]galactose 
are indicated  by the symbols. 
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Figure 3.  Man-6-P receptors acquire sialic acid in three different 
cell lines.  Surface glycoproteins were labeled with [3H]galactose 
using galactosyltransferase as described in Materials and Methods. 
The cells were kept at 4~  or warmed to 37 ~ or 20~  for the times 
indicated.  The 215-kD Man-6-P receptor (o, e), 46-kD Man-6-P 
receptor (zx, &),  and total membrane glycoproteins (D,  =) from 
BW  5147 PHAR1.8 (A),  CHO Idl-D (B),  or CHO clone  13  (C) 
were then prepared and analyzed as described in Materials and 
Methods. The extent of sialylation was calculated as the fraction of 
galactose residues possessing a terminal sialic acid, and was deter- 
mined from the amount of radioactivity eluting as the glycopeptide 
species after exhaustive digestion with 13-galactosidase. In A, the 
filled  symbols indicate  the fraction that was sialylated when the 
cells were labeled at 4~  and then warmed to 37~  for 3.3 h in 
medium containing 0.2 mM cycloheximide. This concentration of 
cycloheximide inhibited protein synthesis by greater than 95 % (data 
not shown).  In B, the filled symbols indicate  the fraction that was 
sialylated when cells were treated with 0.2 mM cycloheximide 1 h 
before labeling and then warmed to 37~  for 3 h in medium again 
containing cycloheximide. In B and C, the half-filled  symbols (e, 
&,  In) indicate the fraction that was sialylated when cells were la- 
beled at 4~  and then warmed to 20~  Panel A represents the com- 
bined results of two experiments (Time = 0, 0.5, 1.5, and 3 h; Time 
=  0, 3.3 h). 
glycopeptide species by gel filtration, and the extent of sialy- 
lation calculated from the fraction of radioactivity eluting as 
glycopeptide. 
Fig.  2  shows  the gel filtration  profiles of [3H]galactose- 
labeled glycopeptides obtained from purified 215-kD Man- 
6-P receptor  (panels  A  and  B),  46-kD  Man-6-P  receptor 
(panels C and D), and total membrane glycoproteins (panels 
E  and  F)  isolated  from  the  BW  5147  PHAR1.8  cell  line. 
~galactosidase digestion of the samples obtained from cells 
incubated at 4~  resulted in nearly all of the pH]galactose 
migrating as free galactose (panels A, C, and E), indicating 
that virtually no terminal sialic acid residues were added to 
the  [3H]galactose-labeled  carbohydrate  chains  under  these 
conditions.  When the ceils were incubated at 37~  for 200 
min before lysis and  analysis,  a  significant  fraction of the 
oligosaccharides  from both Man-6-P  receptors  was sialyl- 
ated. This is shown by panels B and D, in which 30 and 23 % 
of the [3H]galactose residues on the 215-kD and the 46-kD 
Man-6-P receptors, respectively, are resistant to 13-galactosi- 
dase treatment.  Since sialylation is thought to occur in the 
trans-Golgi cisternae and the TGN (6, 48), these data indicate 
that at least a portion of both Man-6-P receptors found at the 
cell  surface can recycle to these compartments.  This phe- 
nomenon is not shared by most cell surface glycoproteins, 
however,  since there was no detectable  sialylation  of total 
membrane glycoproteins (Fig.  2,  panel F). 
Internalization  and  sialylation  of the  Man-6-P  receptors 
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Figure 4. The Man-6-P receptors 
lose sialic acid during incubation 
with  neuraminidase  but  regain 
it once the neuraminidase is re- 
moved. CHO ldl-D cells were met- 
abolically  labeled  with  [3H]ga- 
lactose for 20 h, then chased 2 h 
before adding  Y. cholerae  neur- 
aminidase to the culture medium. 
After 3 or 4 h at 37~  the neur- 
aminidase was removed and the 
37~  incubation  continued.  At 
various times, receptors were pre- 
pared and the extent of sialylation 
of the receptor glycopeptides de- 
termined as before. Panel A, 215- 
kD  Man-6-P  receptor  prepared 
from  two  separate experiments 
where neuraminidase was present 
for 3 (n, ,,), or 4 h (o, e) before 
it was removed. Filled symbols (,,, e) represent glycopeptides treated with mild acid (,,) or an r  2-3 specific neuraminidase (e) to remove 
sialic acid; these glycopeptides were then treated with 13-galactosidase  and the fraction sialylated determined. Where indicated (+CHX), 
0.2 mM cycloheximide was added to the cells at the end of the chase and was present during the remainder of the 37~  incubations. (B) 
The 46-kD Man-6-P receptor prepared from the same experiment where neuraminidase was present for 3 h. 
was also observed in CHO clone 13 cells and CHO ldl-D 
cells, although the extent of sialylation was greater in the BW 
5147 PHAR1.8 cells than in the CHO cells (Fig.  3).  In all 
three cell lines, the rates of sialylation of  both receptors were 
8-10 times greater than the rates observed for the total cell 
surface glycoproteins. 
When the cells were warmed to 20~  instead of 37~  after 
the surface labeling,  little or no sialylation was observed 
(Fig.  3,  panels B  and  C),  consistent with the findings of 
Snider and Rogers that this temperature blocks some aspect 
of  the plasma membrane to Golgi pathway (55). Receptor re- 
cycling does not appear to require the synthesis of lysosomal 
enzymes since  cycloheximide treatment had  no effect on 
receptor sialylation (Fig. 3, panels A and B), regardless of 
whether the inhibitor was added 1 h before surface labeling 
or following the labeling. 
When ldl-D cells are grown in the presence of [3H]galac- 
tose, the sugar is incorporated exclusively into glycoproteins 
and glycolipids as galactose residues. This property allowed 
us to use a second approach to study the sialylation of the 
receptors,  ldl-D  cells  were  grown  in  medium  containing 
[3H]galactose for 20-h to generate Man-6-P receptors with 
complex-type N-linked oligosaccharides terminating in the 
sequence  sialic  acid-[3H]  galactose-N-acetylglucosamine. 
After a 2-h chase,  V. cholerae neuraminidase was added to 
the culture medium for 3-4 h to remove sialic acid residues 
from the receptors which appeared on the cell surface. The 
neuraminidase was then removed, and the chase continued 
to allow those receptors which has lost sialic acid to regain 
it upon return to the Golgi region. The loss or gain of sialic 
acid was  assessed as  in  the previous experiments.  Fig.  4 
shows the results of two experiments done in this manner. 
Before the addition of the neuraminidase to the cultures, 
"-~75  % of  the galactose residues present on the receptors were 
sialylated. The addition of the neuraminidase caused a rapid 
decrease in sialic acid content which leveled off at 20-23 % 
sialylation.  2 After removal of the neuraminidase, both re- 
ceptors began to regain sialic acid. The resialylation of the 
215-kD Man-6-P receptor continued for the next 6-8 h before 
reaching a plateau where 51% of the galactose residues con- 
mined sialic acid (Fig. 4, panel A). Similar results were ob- 
tained with the 46-kD Man-6-P receptor (Fig. 4, panel B). 
The half times for resialylation in these experiments were 
"-,3 h (Table I). The reason why the resialylation does not 
return to the initial level of 75 % is not clear. One possibility 
that we cannot exclude is that a trace amount of added neur- 
aminidase remains bound to the cell surface in spite of the 
extensive washing to remove it.  Interestingly, Rogers and 
Snider using a similar experimental protocol to analyze the 
resialylation of  the transferrin receptor also observed that the 
extent of resialylation was less than the extent of sialylation 
of the native receptor (55). When cycloheximide was present 
during  the  neuraminidase  treatment  and  the  subsequent 
chase, desialylation was slightly decreased and resialylation 
was unaffected (Fig. 4, panel A). This again suggests that the 
synthesis of lysosomal enzymes is not required for receptor 
recycling. 
Two control experiments were performed to demonstrate 
that the resistance of the receptor glycopeptides to 13-galac- 
tosidase was actually due to the presence of blocking sialic 
acid residues.  The glycopeptides were treated with either 
mild acid or an e2-3 specific neuraminidase to remove sialic 
acid prior to the 13-galactosidase  digestion.  Glycopeptides 
treated in this way were almost completely susceptible to the 
2. The most likely explanation for this plateau is that it represents the steady 
state between two competing processes: The loss of sialic acid due to the 
added neuraminidase  and resialylation due to receptor recycling to the TGN. 
If true, the plateau value of 23%  should approximate the t,~ for exposure 
to neuraminidase divided by the t,~ for resialylation. The t,~ for exposure 
to neuraminidase  calculated from the initial rate of sialic acid loss is 30 min. 
Solving for the t~ of sialylation yields a  value of 2.5 h. This calculated 
sialylation half-time is similar to the value of 3 h actually observed in the 
experiment. 
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215-kD  46-kD  Total membrane 
Receptor  Receptor  glycopreteins 
Sialic acid addition 
BW 5147 PHARI.8  3  3  >>3 
CHO ldl-D  3  2.5  >>4 
CHO clone  13  3.5  4  >>12 
Galactose addition (without added galactosyltransferase or UDP-Gal) 
BW 5147  PHARI.8  >>12  >>12 
Mannosidase processing in BW 5147 
With conversion to 
complex-type  20  20  21 
Without conversion 
to complex-type  *  t4  12 
The data shown in Figs. 3,4,6,9, and 10 were used to estimate the relative rates 
of receptor  movement through the compartments containing sialyltransferase, 
galactosyltransferase or  a  deoxymannojirimycin-sensitive mannosidase.  In 
each experiment, the extent of processing at each time point was calculated  ac- 
cording to the general formula: 
Extent of 
processing at =  (T0  =  (% at T~ -  % at T~0 
Time (T)  (% at T~  -  % at T(~) 
The values used for percentage of oligosaccharides processed at T =  eo were 
obtained as follows: The maximal extent of sialic acid addition was estimated 
to be 80% in BW 5147 PHAR1.8 cells (31),  51% in CHO ldl-D cells (Fig. 4) 
and 14 % in CHO clone 13 cells (Fig. 3). The maximal extent of galactose addi- 
tion was estimated to be 95%  based on receptor binding to RCA-1  Agarose 
(Fig.  7). The maximal extent of conversion of high mannose units to complex- 
type units was estimated from the ratio of these two types of structures on the 
receptors of control cells (Fig. 9, panels A and B). The actual cpm in each type 
of oligosaccharide was divided by its content of mannose and fucose residues 
(average of 4  for complex-type and 8  for high mannose units) to calculate 
molecules of oligosaccharide.  The  maximal extent of mannose processing 
without conversion to complex-type units was calculated by adding the amount 
of Man5.+GIcNAc2 species present on the proteins in control cells (Fig.  9, 
panels A-C and Fig.  10, panels A-C) plus the amount of Man~GlcNAc:  ex- 
pected due to the percentage of complex-type species formed in control cells 
(the  complex-type  species  being  derived  from  the  MansGIcNAc2  inter- 
mediate). 
The extent of processing at each time point was used to calculate a half-time 
assuming the processing obeyed first order kinetics, and the individual  half 
times were averaged within an experiment. In the cases of galactose addition 
to the receptors and sialic acid addition to total  glycoproteins, little  or no 
oligosaccharide processing was observed over the course of the experiment. In 
these instances, the half-time of processing was estimated to be much longer 
than the longest available time point. 
* A t~ could not be accurately calculated since the data do not fit a first order 
decay reaction. 
I~-galactosidase  (Fig.  4,  panel  A). 3  These  results  demon- 
strate that the 13-galactosidase-resistant  glycopeptides con- 
tain sialic acid. 
Receptors do not Return to the Golgi Compartment 
Containing Galactosyltransferase 
Since the above results demonstrated that the receptors re- 
cycle to the trans-Golgi/TGN compartment containing sialyl- 
transferase, we next asked whether they also recycle to the 
Goigi compartment containing galactosyltransferase and ac- 
quire galactose. Galactosyltransferase  is a late acting enzyme 
which has been immunolocalized  to the trans-Golgi cisternae 
in HeLa cells (47) and to this same region as well as the TGN 
3.  The slightly greater effect observed with the mild acid treatment most 
likely reflects the fact that acid treatment is more efficient than neuramini- 
dase in releasing all of the sialic acid. Alternatively, the differences could 
be due to the presence of some ~t2-6 linked sialic acid that would not be 
cleaved by the ct2-3 specific neuraminidase. 
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Figure 5. The mature Man-6-P receptors do not acquire galactose, 
BW  5147  PHAR1.8  cells  were  labeled  with  [3H]mannose  and 
chased for the times indicated. Both Man-6-P receptors were then 
isolated and the fraction containing gatactose assessed by chroma- 
tography on RCA-I Agarose. The arrows indicate where the 0.2 M 
galactose was included in the column buffer to elute those receptors 
containing  galactose.  (A-D)  215-kD  Man-6-P  receptor  isolated 
from cells chased 6, 8, 12 and 18 h, respectively. (E-H) 46-kD Man- 
6-P receptor isolated from cells chased 6,  8,  12 and  18 h,  respec- 
tively. 
in  HepG2  cells  (28).  In  the biosynthesis of oligosaccha- 
rides, it acts just before sialyltransferase. BW 5147 PHAR1.8 
cells were used for this experiment since preliminary experi- 
ments had indicated that the defect in galactose addition in 
these cells was not complete, i.e., the glycoproteins synthe- 
sized by this cell line acquired a small amount of galactose 
during  their  initial  passage  through  the  Golgi  complex. 
Therefore, in these cells, if the receptors returned to the re- 
gion  of the  Golgi  containing  galactosyttransferase,  they 
should acquire additional galactose residues with each pass. 
The cumulative effect of multiple trips could then be mea- 
sured as increased binding of the receptors to the galactose- 
specific lectin, RCA-1 (1). 
To test this possibility, cells were grown in the presence 
of [3H]mannose for 40 min to metabolically label the recep- 
tors and then chased for 6-18 h before harvesting. The mini- 
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Figure 6. Effect of neuraminidase treatment on Man-6-P receptor 
binding to RCA-1 Agarose. Aliquots of  the 215-kD and 46-kD Man- 
6-P receptors isolated in the experiment described in Fig. 5 were 
treated with V. cholerae neuraminidase and analyzed for binding to 
RCA-I Agarose. (o, e) 215-kD receptor; (zx, ￿9  46-kD receptor. 
(Open symbols) no  neuraminidase  treatment;  (closed symbols) 
neuraminidase treatment. 
mum chase of 6 h insured that the radiolabeled receptors had 
completed their first pass through the Golgi region (31). The 
two receptors were purified and the fraction capable of  bind- 
ing to RCA-1 Agarose determined. As shown in Fig. 5, a por- 
tion of both receptors obtained from cells at the end of the 
6-h chase bound to the lectin, demonstrating partial galac- 
tosylation (panels A and E). This binding did not increase 
during the next 12 h of chase, indicating that neither receptor 
acquired additional galactose residues (Fig. 5, panels B-D 
and F-H). Since substitution of galactose residues by sialic 
acid can reduce the affinity of  the oligosaccharide for the lec- 
tin (1), the binding of RCA-1 Agarose was redetermined after 
V. cholerae neuraminidase treatment. As shown in Fig. 6, 
this treatment had no effect  on binding of the 215-kD Man-6- 
P receptor to the lectin and only a small effect on binding of 
the 46-kD Man-6-P receptor. Therefore, the failure to ob- 
serve a progressive increase in lectin binding was not due to 
the acquisition of "blocking" sialic acid residues. 
To prove that the mature receptors could serve as sub- 
strates for galactosyltransferase and that galactose acquisi- 
tion would cause an observable increase in RCA-1 Agarose 
binding,  the experiment was  repeated with  UDP-Gal and 
galactosyltransferase added to the culture medium during the 
chase. Under these conditions, both receptors acquired suf- 
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Figure 7. The Man-6-P receptors can acquire galactose when galac- 
tosyltransferase and UDP-galactose are added to the culture medi- 
um. BW 5147 PHAal.8 cells were labeled with [3H]mannose and 
chased 6 h. Galactosyltransferase, UDP-Gal and MnCI2 were then 
added (final concentrations 0.05 U/ml, 0.54 mM and 10 mM, re- 
spectively) to the medium and the 37~  incubation continued. Ad- 
ditional UDP-Gal (0.5 ~tmol per ml) was added every 30 min. The 
fraction of  the 215-kD (A) or 46-kD (B) Man-6-P receptors capable 
of binding to RCA-I Agarose with (e, A) or without (o, A) prior 
V.. cholerae neuraminidase treatment was determined as described 
in Materials and Methods. Where indicated (4~  cells were la- 
beled with pH]mannose and then chased 6 h at 37~  The ceils 
were  cooled  to 4~  then  UDP-Gal, galactosyltransferase and 
MnC12 were added and the 4~  incubation continued for 2 h. 
Thereafter, the fraction of each receptor containing galactose was 
determined as above. 
ficient galactose so that greater than 90% of each bound to 
the lectin (Fig. 7). The half-time of this process was 2 h for 
the 215-kD Man-6-P receptor and 2.5 h for the 46-kD Man- 
6-P receptor. This galactosylation was temperature-depen- 
dent since cells  incubated with  UDP-Gal  and galactosyl- 
transferase at 4~  for 2 h manifested only a slight increase in 
lectin binding (Fig. 7), presumably due to galactose addition 
to the small fraction of receptors present on the cell surface 
(23).  Since almost all of the receptor molecules acquired 
galactose residues, the total pool of receptors would appear 
to be in equilibrium even though only a small percent is pres- 
ent on the cell surface at any point in time. 
In  similar  experiments performed  with  CHO  clone  13 
cells, the same result was obtained in that the receptors only 
acquired galactose when the cells were exposed to exogenous 
UDP-Gal  and galactosyltransferase.  However, in  this  cell 
line the rate of galactose addition to the receptors was sig- 
nificantly faster with the half-time being 30 min for the 215- 
kD  receptor and  <1  h  for the  46-kD  receptor (data  not 
shown).  We conclude from these experiments that neither 
receptor acquires additional galactose residues after its ini- 
tial pass through the Golgi region even though the receptors 
are good substrates for galactosyltransferase. These data in- 
dicate that the receptors do not recycle to the Golgi compart- 
ment containing galactosyltransferase. 
As shown in Fig. 7, panel B, the 46-kD Man-6-P receptor 
isolated from cells incubated with galactosyltransferase and 
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Figure 8. Experimental protocol used to determine whether recep- 
tor molecules  return  to the early Golgi compartment  containing 
ct-mannosidase I.  The  symbols  represent:  (a)  N-acetylglucos- 
amine; (o) mannose; (e) galactose; (&) sialic acid. 
UDP-Gal bound completely to RCA-1 Agarose only after it 
was  treated  with  neuraminidase.  This  indicates  that  the 
receptor had acquired sialic acid after the addition of galac- 
tose, as would be predicted from the previous experiments 
on resialylation of the receptor. The effect of neuraminidase 
on binding of the 215-kD receptor to the RCA-1 Agarose was 
much smaller (Fig. 7, panel A). This most likely reflects the 
fact that the 215-kD receptor has more glycosylation sites 
which might allow binding to the lectin even when the galac- 
tose residues are sialylated (17, 42). 
Receptors Rarely Recycle Through the Golgi Region 
The approach used to determine whether the Man-6-P recep- 
tors or other glycoproteins return to the early Golgi complex 
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Figure 9. Con A-Sepharose chromatography of glycopeptides iso- 
lated from BW 5147 cells incubated with or without dMM.  Parent 
BW 5147 cells  were labeled  with  [3H]mannose for 40  min and 
chased 6 h in the presence (D-O) or absence (A-C) of 0.25 mM 
dMM.  The inhibitor was removed and the cells recultured  for 3 
(G-l), 6 (J-L) or 12 (M-O) h. Both Man-6-P receptors as well as 
total glycoproteins  were  isolated and  digested to glycopeptides. 
Conversion of high mannose-type to complex-type oligosaccharide 
units was assessed by Con A-Sepharose chromatography. The col- 
umns were washed with Tris-buffered saline and eluted with 10 mM 
ct-methylglucoside (G) and 100 mM a-methylmannoside (M) at the 
indicated points. (A, D, G, J, and M) 215-kD Man-6-P receptor; 
(B, E, H, K, and N) 46-kD Man-6-P receptor; (C, F, I, L, and O) 
total membrane glycoproteins. 
and encounter Golgi a-mannosidase I is outlined in Fig.  8. 
This approach takes advantage of a  reversible inhibitor of 
Golgi a-mannosidase I, deoxymannojirimycin (dMM)  (8). 
Cells incubated in the presence of the inhibitor produce gly- 
coproteins  which  retain  their  high  mannose  structures  as 
they pass through the Golgi complex whereas under normal 
circumstances  many  of  these  oligosaccharides  would  be 
processed to complex-type units.  After allowing  sufficient 
time  for  the  glycoproteins  to  complete  their  initial  pass 
through the Golgi region, the inhibitor is removed. During 
the subsequent incubation, any glycoprotein that recycles back 
through the Golgi region should encounter an active Golgi 
a-mannosidase I and have its high mannose oligosaccharides 
trimmed. Subsequent processing enzymes would then con- 
vert the trimmed high mannose units to complex-type units 
(38).  The conversion from high mannose to complex-type 
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Figure 10. Size of the high mannose oligo- 
saccharides isolated from Man-6-P recep- 
tors  and  total  glycoproteins.  The  0.1-M 
ct-methylmannoside eluates from the Con 
A-Sepharose  columns  (Fig. 9)  were  de- 
salted, concentrated by evaporation under 
reduced pressure, and digested with 2.5 mU 
of endo H. The digests were applied to Am- 
berlite MB3 minicolumns in water and an 
aliquot of  the released, neutral oligosaccha- 
rides  was  taken  to dryness,  dissolved in 
35 % aqueous acetonitrile, and applied to an 
AX5  micropak  high  performance  liquid 
chromatography column (Varian). The oli- 
gosaccharides were eluted using a 60-ml 
linear  gradient  from 35 to 65%  aqueous 
acetonitrile; 0.6-ml fractions were collected 
and diluted with 4 rnl of scintillation fluid 
for radioactivity determination. The arrows 
in A indicate the elution position of the fol- 
lowing high mannose oligosaccharide units: 
MansGlcNAc (5), Man6GlcNAc (6), Man7 
GIcNAc (7),  MansGlcNAc (8), and Man9 
GlcNAc (9). The labeling of the panels is 
identical to that in Fig. 9. 
units can be conveniently followed by analyzing the Asn- 
linked oligosaccharides on Con A-Sepharose columns. Un- 
der the elution conditions employed, complex-type units ei- 
ther pass  through the column (peak I) or are eluted with 
10 mM  r  (peak II) while high  mannose- 
type  oligosaccharides  bind  tightly  and  require  100  mM 
tt-methylmannoside for elution (peak III) (31, 40, 43). Thus, 
processing of high mannose to complex-type units would be 
reflected by a shift of material from peak III to peaks I and 
II. Preliminary experiments showed that 250-500 laM dMM 
inhibited oligosaccharide processing of total cellular glyco- 
proteins by greater than 80%  and that the effect was  fully 
reversed within 30 min after the dMM was removed from the 
medium (data not shown).  These results are in agreement 
with those reported by Snider and Rogers (56). 
Using the protocol shown in Fig. 8, parent BW 5147 cells 
were incubated with [3H]mannose for 40 rain in the pres- 
ence of 0.25 mM dMM and then chased for 6 h in the pres- 
ence ofdMM. The 6-h chase allowed the newly synthesized 
receptors to exit the rough endoplasmic reticulum and com- 
plete their initial pass through the Goigi region (31).  The 
dMM was then removed and the chase continued for 12 more 
h. At various intervals, cells were harvested and the Man-6-P 
receptors isolated.  Glycopeptides were prepared from the 
receptors and analyzed on Con A-Sepharose columns. The 
results are shown in Fig.  9.  In the absence of dMM,  both 
receptors contain high mannose and complex-type oligosac- 
charide units (Fig. 9, panels A and B). The addition ofdMM 
to the medium during [3H]mannose labeling and chase in- 
hibited  complex-type oligoscaccharide formation (Fig.  9, 
panels D and E). After removal of the dMM, the high man- 
nose oligosaccharides in peak III were converted to complex- 
type species (peaks I and II) extremely slowly (Fig. 9, panels 
G, H, J, K, M, and N). The half-times of conversion from 
high mannose to complex-type oligosaccharides was ~20 h 
for both receptors. Similar results were obtained with the to- 
tal membrane glycoproteins where the half-time of process- 
ing was estimated to be 21 h (Fig. 9, panels C, F, I, L, and 
O). These results, which are summarized in Table I, indicate 
that the Man-6-P receptors as well as other membrane glyco- 
proteins rarely recycle through the cis/middle Golgi region 
where the enzymes required to convert high  mannose to 
complex-type structures are concentrated. 
We next considered the possibility that the receptors might 
only be exposed to Golgi ct-mannosidase I, i.e., they might 
enter and exit the compartment containing a-mannosidase I 
without proceeding to the compartments containing the sub- 
sequent  oligosaccharide-processing  enzymes.  If this  oc- 
curred the high mannose oligosaccharides would be pro- 
cessed from the Mans_gGlcNAc2 species to MansGlcNAc2 
without conversion to complex-type molecules (38). To ad- 
dress this possibility, the peak III glycopeptides were treated 
with endo H to release the oligosaccharides and the distribu- 
tion of sizes (Man5 to Mang) determined by HPLC analysis. 
As shown in Fig. 10, there was a gradual shift in oligosaccha- 
ride  size  from  Mans_gGlcNAc  to  smaller  forms  for both 
Man-6-P receptors and total glycoproteins. In the case of the 
46-kD receptor, the shift was quite slow and very similar to 
that observed for the total membrane glycoproteins. By tak- 
ing  the  conversion  of  the  Mans_gGlcNAc2  species  to 
Man~_6GlcNAc2 as a measure of Golgi a-mannosidase I ac- 
tion, the processing could be shown to occur by a first order 
reaction, with a calculated t,~ of 14 h for the processing of 
the 46-kD receptor oligosaccharides and  12 h  for the pro- 
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rides. While the rate of processing of the high mannose units 
of the 215-kD receptor was somewhat faster than that ob- 
served with the 46-kD receptor, the kinetics of the process- 
ing were complex and did not obey a first order decay curve. 
For this reason, we could not calculate a valid t,~ for this 
processing.  However,  by  comparing  these  data  with the 
values obtained for the 46-kD receptor and the total mem- 
brane glycoproteins, we estimate the t,/~ of the mannose pro- 
cessing to be between 6-13 h. Thus, the shortest t,~ is twice 
as long as the t,/2 for sialic acid addition in this cell type. 
These data indicate that neither Man-6-P receptor routinely 
enters and exits the early Golgi compartment that contains 
the ~t-mannosidase  I. 
In a separate experiment, swainsonine was added to deter- 
mine if the mannose loss could be attributed to the swainso- 
nine-sensitive lysosomal mannosidase (8). For oligosaccha- 
rides prepared from the 215-kD receptor,  swainsonine did 
not affect the shift from Mans_gGlcNAc2 to Mans_6GlcNAc2 
during a 6-h reculture (data not shown). This indicates that 
a dMM-sensitive, swainsonine-resistant ct-mannosidase me- 
diates this processing. 
Discussion 
We have used the compartmentalization of oligosaccharide 
processing enzymes in the Golgi apparatus as a means for 
studying the cycling of the Man-6-P  receptors to various 
regions of that organelle. The methods used in this study 
measure the flux of receptor through the various Golgi com- 
partments in contrast to immunolocalization and subcellular 
fractionation techniques which measure steady state concen- 
trations. Hence this approach gives a better indication of the 
actual movement of receptors to the various regions of the 
Golgi. Using these methods, several significant findings have 
emerged.  First, both the 215-kD and the 46-kD  Man-6-P 
receptors cycle between the cell surface and the Golgi region 
and do so at a similar rate. The finding that the 46-kD Man- 
6-P receptor cycles to the Golgi region suggests that this pro- 
tein actually functions as a receptor rather than serving as 
a static-binding protein. The surface galactosylation experi- 
ment (Fig. 7) resulted in virtually all of the receptor mole- 
cules acquiring galactose residues. One explanation for this 
is that the total pool of receptor molecules is in equilibrium 
even though only a small percentage of the molecules are on 
the cell surface at any point in time. Alternatively, since the 
experiments were carried out at 37~  it is possible that some 
of the galactosyltransferase and UDP-galactose entered en- 
dosomal compartments and acted on a  subset of receptors 
that cycle between these compartments and the Golgi region 
without passing through the cell surface. Since the sialyla- 
tion experiments document that the receptors cycle between 
the cell surface and the Golgi complex, presumably by pass- 
ing through intermediate endosomal compartments, we favor 
the concept that there is only one pool of receptor molecules 
which cycle between all the compartments. Previous investi- 
gators using different techniques have also concluded that all 
of the 215-kD Man-6-P receptor is in equilibrium (16, 53, 
63). However, these studies share the same potential pitfall 
as the galactosyltransferase experiments. The cycling of the 
46-kD Man-6-P receptor was not analyzed in these studies. 
To study whether receptor cycling is affected by ligand 
binding, cycloheximide was added in several experiments to 
inhibit the synthesis of lysosomal enzymes, thereby remov- 
ing the source of ligand. Under these conditions, receptor 
flux through the various compartments was not significantly 
altered,  indicating that both receptors cycle constitutively. 
Braulke et al. and Pfeffer came to the same conclusion using 
different methods to analyze the cycling of the 215-kD Man- 
6-P receptor (10, 45). However, these experiments do not rule 
out the possibility that ligand binding might facilitate certain 
steps in receptor recycling, thereby changing the steady state 
concentration of receptor in specific compartments (14, 15). 
The major conclusion from these studies is that both Man- 
6-P receptors return to the Golgi compartment containing 
sialyltransferase much more frequently than to the Golgi 
regions containing galactosyltransferase  or a-mannosidase I. 
Since  sialyltransferase has  been  immunolocalized to  the 
trans-Golgi  cisternae  and  the  TGN  (48),  whereas  galac- 
tosyltransferase has been immunolocalized to the trans-Golgi 
cisternae (47)  and ct-mannosidase I is considered to be a 
cis/middle  Golgi marker (2-4), we conclude that the recep- 
tors are returning to the TGN. On this basis we propose that 
in the cell types examined the TGN is the major site where 
lysosomal enzymes encounter the Man-6-P receptors. This 
proposal is consistent with a wide range of morphologic and 
biochemical data. Geuze et al. (28) and Griffiths et al. (33) 
have shown that the 215-kD Man-6-P receptor is present in 
the TGN with lesser amounts being detected in the Golgi 
stack. In agreement with our observation that the receptors 
do not return to the compartment containing galactosyltrans- 
ferase, Geuze et al. found little overlap in the distribution of 
galactosyltransferase  and the 215-kD Man-6-P receptor when 
both were immunolocalized in HepG2 cells (28).  Further- 
more, Berger et al. using double immunofluorescence label- 
ing in HeLa cells found galactosyltransferase  and sialyltrans- 
ferase to be localized in different subcellular compartments 
(7). The finding that several lysosomal enzymes contain ter- 
minally processed complex-type N-linked oligosaccharides 
indicates that these enzymes traversed the Golgi complex as 
would be expected if sorting occurred in the TGN (5, 22, 29, 
41, 46, 61). 
Brown and Farquhar have recently used the immunoperox- 
idase technique to localize the 215-kD Man-6-P receptor in 
three cell types (13). They found the receptor to be concen- 
trated in the cis Golgi region of Clone 9 cells, in the TGN 
of CHO cells and throughout the Golgi region of NRK cells. 
They concluded that the distribution of the 215-kD receptor 
within the Golgi complex varies from one cell type to an- 
other and may reflect variations in lysosomal enzyme traf- 
ticking among different cell types. It should be noted that 
their data on the localization of the 215-kD Man-6-P receptor 
in CHO cells is in agreement with our kinetic studies of this 
cell type. 
As part of this study we also examined the return of total 
membrane glycoproteins (minus the Man-6-P receptors) to 
the  Golgi  compartments  containing  sialyltransferase and 
tt-mannosidase I. The sialylation of the cell surface glyco- 
proteins was detectable but was extremely slow when com- 
pared with the Man-6-P receptors. This indicates that either 
the total cell surface glycoproteins cycle through the TGN at 
a very slow rate or that a small subset of these molecules cy- 
cles at a rate comparable to that of the Man-6-P receptors 
with the remainder of the molecules not returning to this 
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vation  that  in  K562  erythroleukemia  cells  the  transferrin 
receptor is  resialylated  with a  t,h  of 2-3  h  (55).  We also 
found  that  the  return  of total  glycoproteins  to  the  Golgi 
compartment  containing  r  I  was  quite  slow, 
whether measured by the conversion of high mannose units 
on the  glycoprotein to  complex-type units  (e.g.,  return to 
early Golgi stacks followed by transit through the Golgi re- 
gion) or as determined by the processing of Man7_gGlcNAc 
species  to  Mans.6GlcNAc  species.  The  calculated  t,~'s for 
these events  were 20 and  12 h, respectively.  The t,~ of 12 h 
for mannose  processing  may  actually  be  an  overestimate 
of the  true  rate  of return  to the  early  Golgi  region  since 
dMM-inhibitable  ~t-mannosidases  are  known  to  exist  in 
other compartments, such as the endoplasmic reticulum (9). 
Based on the paucity of sialic acid addition and the slow rate 
of conversion from high mannose to complex-type oligosac- 
charides, we conclude that glycoproteins as a whole do not 
routinely  recycle through  the Golgi  region in murine BW 
5147  lymphoma cells.  This conclusion differs  significantly 
from that drawn from similar experiments  reported by Snider 
and Rogers on the return of the transferrin receptor and other 
glycoproteins  to  the  early  Golgi  compartments  in  K562 
erythroleukemia cells  (56).  These workers calculated that 
the transferrin receptor and total glycoproteins return to the 
Golgi compartment containing ct-mannosidase  I with t,~'s of 
>6 and 4 h, respectively. These differences may reflect the 
method used for calculating half times,  some variations  in 
experimental design and cell-to-cell variation. 
Griffiths and Simons have recently proposed that the TGN 
is the site where newly synthesized proteins destined for the 
plasma  membrane,  secretory  vesicles  and  lysosomes  are 
sorted and packaged into the correct transport vesicles (32). 
Our finding that both Man-6-P receptors return to the Golgi 
compartment containing sialyltransferase  and rarely recycle 
through other regions of the Golgi is totally  consistent with 
this  model. 
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